Gadolinium Claim Time-Barred By Plaintiff’s Admission To FDA Committee
CLEVELAND — An Ohio federal judge on May 15 dismissed a woman’s gadolinium contrast agent injury lawsuit as time-barred after defendant Bayer Healthcare Pharmaceuticals Inc. turned up the plaintiff’s public testimony...To view the full article, register now.
Already a subscriber? Click here to view full article